Office Hours… Nick Mourlas, Johnson & Johnson Innovation, New Ventures

Add this event to your calendar:
28/04/2016 10:30 28/04/2016 18:30 America/Los_Angeles Office Hours… Nick Mourlas, Johnson & Johnson Innovation, New Ventures JLABS @ SSF , 3rd Floor - Dubai Conference Room , South San Francisco , CA JLABS Bay Area false DD/MM/YYYY
April
28
Event

Office Hours… Nick Mourlas, Johnson & Johnson Innovation, New Ventures

JLABS @ SSF , 3rd Floor - Dubai Conference Room , South San Francisco , CA

April 28, 2016 from 10:30 AM to 18:30 PM (PDT)

$10 - $35


Making connections to the correct resources is one of the goals of the Johnson & Johnson Innovation, JLABS program. In order to facilitate the process, we are continuing our one-on-one meetings with Johnson & Johnson Innovation team members. We are happy to announce that Nick Mourlas, Senior Director New Ventures, will be available on Thursday, April 28th for 1-on-1 meetings with JLABS companies. Nick is looking forward to finding ways to leverage his role at Johnson & Johnson Innovation to help your business succeed. Please sign up for a timeslot below (one per company please).


Start times:
8:30 am
9:15 am
10:00 am
10:45 am
11:30 pm
1:00 pm
1:45 pm
2:15 pm
3:15 pm
4:00 pm

Meeting time is 30 Minutes . Please email by April 21st, a brief, high level pitch deck in order to help Nick prepare for your meeting. Email the deck to Shirley.

Please be prepared to discuss your current progress, short and long term milestones and your thoughts on key areas of cooperation that would be beneficial to your success.


Location:
JLABS @ SSF
Dubai Conference Room - 3004
329 Oyster Point Blvd - 3rd Floor
South San Francisco, California
Map It


Biography:
Nick Mourlas | Senior Director of New Ventures, Johnson & Johnson Innovation, California
Nick's role within New Ventures focuses on medical device innovation in support of the general surgery, orthopedics, and cardiology businesses. His charge is to identify licensing, collaboration, and investment opportunities highly aligned with J&J business strategies by building relationships with entrepreneurs, venture investors, and key opinion leaders. Nick and the New Ventures team employ a broad array of deal structures in order to best fit the specific needs of the innovation opportunity, as appropriate collaborating with JJDC (equity investments) and JLABS (incubator).
Previously he served as PARC's Director of Global Healthcare Innovation and as the Xerox Innovation Group's Healthcare Program Manager. His focus was on developing and executing a high-impact innovation strategy that aligned with the long-term roadmap of the Xerox healthcare businesses by identifying and understanding emerging trends in healthcare and technology.
Nick's start-up experience includes founding companies is orthopedics, cardiology, and radiation oncology. He was the CEO of Tarsus Medical - acquired by Integra LifeSciences (IART), and Acumen Medical - acquired by Medtronic (MDT).
Dr. Mourlas holds a Ph.D. in Electrical Engineering from Stanford University where he was the John B. Simpson Biomedical Innovation Technology Fellow in the inaugural year of Stanford's Biodesign Fellowship Program. He also received his AB in Engineering Sciences from Dartmouth College, and a BE from Dartmouth's Thayer School. He regularly guest lectures at Dartmouth College and Stanford on the topic of medical device innovation.
Connect with Nick: Connect on LinkedIn


JLABS Bay Area

About Johnson & Johnson Innovation, JLABS Johnson & Johnson Innovation, JLABS (JLABS) is a global network of open innovation ecosystems, enabling and empowering innovators to create and accelerate the delivery of life-saving, life-enhancing health and wellness solutions to patients around the world. JLABS achieves this by providing the optimal environment for emerging companies to catalyze growth and optimize their research and development by opening them to vital industry connections, delivering entrepreneurial programs and providing a capital-efficient, flexible platform where they can transform the scientific discoveries of today into the breakthrough healthcare solutions of tomorrow. At JLABS we value great ideas and are passionate about removing obstacles to success to help innovators unleash the potential of their early scientific discoveries. JLABS is a no-strings-attached model, which means entrepreneurs are free to develop their science while holding on to their intellectual property. JLABS is open to entrepreneurs across a broad healthcare spectrum including pharmaceutical, medical device, consumer and healthtech sectors. The JLABS flagship opened in 2012 in San Diego at Janssen's West Coast Research Center, and since then has grown to ten global locations including the Bay Area, Boston & Lowell, MA, Houston, Toronto, Beerse (Belgium), with New York City, opening in June 2018, and Shanghai in 2019. For more information please visit www.jlabs.jnjinnovation.com or follow @JLABS. About Johnson & Johnson Innovation Johnson & Johnson Innovation LLC focuses on accelerating all stages of innovation worldwide and forming collaborations between entrepreneurs and Johnson & Johnson's global healthcare businesses. Johnson & Johnson Innovation provides scientists, entrepreneurs and emerging companies with one-stop access to science and technology experts who can facilitate collaborations across the pharmaceutical, medical device and consumer companies of Johnson & Johnson. Under the Johnson & Johnson Innovation umbrella of businesses, we connect with innovators through our regional Innovation Centers, Johnson & Johnson Innovation | JLABS, Johnson & Johnson Innovation - JJDC, Inc. and our Business Development teams to create customized deals and novel collaborations that speed development of innovations to solve unmet needs in patients. For more information please visit www.jnjinnovation.com or follow @JNJInnovation.

Event contact


Related content